0001567619-22-018275.txt : 20221005 0001567619-22-018275.hdr.sgml : 20221005 20221005164057 ACCESSION NUMBER: 0001567619-22-018275 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221005 DATE AS OF CHANGE: 20221005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stanker James H CENTRAL INDEX KEY: 0001681718 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 221296157 MAIL ADDRESS: STREET 1: 9008 SHADYBROOK DRIVE CITY: FREDERICK STATE: MD ZIP: 21701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 4/A 1 doc1.xml FORM 4/A X0306 4/A 2022-09-30 2022-10-03 0 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001681718 Stanker James H C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 0 1 0 0 Chief Financial Officer Restricted Stock Units 0 2022-09-30 4 A 0 12950 0 D Common Stock 12950 339663 D Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death. Previous filing inadvertently underreported derivative securities beneficially owned by the reporting person. /s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact 2022-10-05